Injectables
Is Xeomin FDA Approved? Status, Indications, and What "Naked" Tox Means
Yes—Xeomin is FDA-approved for cosmetic and therapeutic use. Here's what medspa owners need to know about this naked botulinum toxin option.
Photo: Youssef Labib / Pexels
AI Inside MedSpa Intelligence · Jun 26, 2026
Yes, Xeomin Is FDA Approved
Xeomin is FDA-approved for both cosmetic and medical indications. It is a purified botulinum toxin type A product manufactured by Evolus Inc., and it competes directly with Botox and Dysport in the aesthetic market.
What Makes Xeomin "Naked" Toxin?
Xeomin's key differentiator is that it is a "naked" botulinum toxin—meaning it contains no complexing proteins around the active neurotoxin molecule. Botox and Dysport, by contrast, are supplied with accessory proteins that stabilize the toxin during storage and transport.
The theory behind naked toxin is that:
- Fewer proteins may reduce the risk of antibody formation (resistance over time)
- The product may have a faster onset in some patients
- It may offer a cleaner, more predictable diffusion pattern
However, clinical evidence on whether these theoretical advantages translate to meaningful practice benefits remains mixed. Many practitioners report similar results across all three major brands.
Xeomin's "naked" formulation contains no complexing proteins, but clinical evidence on real-world advantages over Botox or Dysport remains mixed.
FDA-Approved Indications
Cosmetic use: Xeomin is approved for the temporary improvement of moderate to severe glabellar lines (frown lines between the eyebrows) in adults.
Therapeutic use: Xeomin is also approved under the brand name Xeomin for cervical dystonia and blepharospasm—conditions that fall outside the typical medspa scope but may be relevant if your practice offers medical aesthetics or neurology services.
Practical Considerations for Owners
Xeomin has a smaller market share than Botox or Dysport in most U.S. aesthetic practices, which can affect:
- Pricing power: Patients may expect lower costs than Botox
- Supply and distributor relationships: Verify availability and pricing with your current suppliers
- Patient familiarity: Many patients arrive asking specifically for Botox; staff education on alternatives is important
- Dosing: Xeomin uses the same unit-based dosing as Botox, making conversion straightforward
Always verify current FDA status, approved indications, and pricing with the manufacturer and your state board, as regulatory approvals and market conditions can shift.
Frequently asked questions
Is Xeomin FDA approved for cosmetic use?
Yes, Xeomin is FDA-approved for the temporary improvement of moderate to severe glabellar lines (frown lines between the eyebrows) in adults. It is manufactured by Evolus Inc. and competes directly with Botox and Dysport in the aesthetic market.
What does naked botulinum toxin mean?
Naked toxin means Xeomin contains no complexing proteins around the active neurotoxin molecule, unlike Botox and Dysport which include accessory proteins for stabilization. The theory is that fewer proteins may reduce antibody formation, offer faster onset, and create more predictable diffusion, though clinical evidence on these benefits remains mixed.
Can you convert Xeomin dosing from Botox units?
Yes, Xeomin uses the same unit-based dosing as Botox, making conversion straightforward for practitioners already familiar with Botox dosing protocols.
Why is Xeomin cheaper than Botox?
Xeomin has a smaller market share than Botox or Dysport in most U.S. aesthetic practices, which affects pricing power—patients often expect lower costs than the more established Botox brand, even though the active ingredient is the same botulinum toxin type A.
What are the medical uses of Xeomin?
Beyond cosmetic use, Xeomin is FDA-approved for cervical dystonia and blepharospasm under therapeutic indications. These medical applications fall outside typical medspa scope but may be relevant for practices offering medical aesthetics or neurology services.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief every morning. The owners who read it never get blindsided.
Get the edge · $20/mo Join the owners who run ahead of the industry. Cancel anytime, one click.
